The VMD has issued the below statement following the recall of Dechra Pharmaceuticals PLC products. We wish to inform wholesalers that Dechra Pharmaceuticals PLC has initiated a Class II recall to wholesaler level with immediate effect for the following products: • Ophtocycline 10 mg/g eye ointment for dogs, cats and horses, Vm41821/4043 • Equipalazone 200 mg/ml Solution for Injection Vm50406/3037 & Vm50406/5042 The reason for the recall is due to an increased risk of microbial con

This medicines update is provided by the Veterinary Medicines Directorate (VMD) and lists new active substance, new marketing authorisations and changes to authorisations most relevant to vets. New marketing authorisations The below table shows the new marketing authorisations for September 2025. New Marketing Authorisations Product name and target species Active substance Authorisation Holder, territory, and distribution category Therapeutic group Food Animals BioEquin F Suspension for Inject

Major collaborative initiative launched to tackle challenge of demonstrating responsible antibiotic stewardship in the UK ruminant sector A new collaborative initiative has launched to co-develop a ‘roadmap’ to support the UK ruminant sector in tackling the challenge of improving - and proving - responsible antibiotic stewardship (ABS). Although UK farming has cut antibiotic use by almost 60% in the last decade and is estimated to have very low use in cattle and sheep sectors, exact